Target intelligence / Profile preview

Aconitase 1 (ACO1)

Target
ACO1
Molecular classification
Enzyme, RNA-binding protein, Iron-sulfur protein, Metabolic enzyme, Other
01

Overview

Aconitase 1 (ACO1) is a bifunctional cytosolic enzyme that acts both as an aconitase in the tricarboxylic acid (TCA) cycle and, under iron-deficient conditions, as a posttranscriptional regulator of iron metabolism by binding iron-responsive elements in mRNAs. When cellular iron is abundant, ACO1 incorporates a [4Fe-4S] cluster and catalyzes the conversion of citrate to isocitrate. When iron is scarce and the Fe-S cluster is lost, ACO1 switches to an RNA-binding form, regulating the stability and translation of mRNAs encoding key iron homeostasis proteins such as ferritin and the transferrin receptor. This dual function positions ACO1 as a critical sensor and effector in cellular iron balance, and its dysfunction is implicated in disorders of iron metabolism and some neurodegenerative diseases[1][2][3].

Other names
Iron regulatory protein 1IRP1Iron-responsive element-binding protein 1IREB1IREBPIREBP1Aconitate hydratase, cytoplasmicCytoplasmic aconitate hydrataseFerritin repressor proteinSoluble aconitaseACONSHEL60Cytosplasmic aconitase
02

Mechanism of action

Not classically pharmacologically targeted; mechanistic action involves inhibition or modulation of enzymatic activity or protein–RNA binding, but no drugs directly approved or standardly used to target ACO1[1][2][3].

03

Biological functions

Iron homeostasis regulationCitrate to isocitrate conversion (TCA cycle)Posttranscriptional regulation of iron metabolism genesRNA binding (to iron-responsive elements)
04

Disease associations

AnemiaNeurodegenerative diseaseHemochromatosisFriedreich ataxiaOther disorders related to dysregulated iron metabolism
05

Safety considerations

Disruption of iron homeostasis (risk of cellular iron overload or deficiency)Potential for mitochondrial toxicity if iron supply is impairedOff-target metabolic consequences due to TCA cycle perturbation
06

Biomarkers

Iron regulatory pathway gene/protein expression (e.g., ferritin, transferrin receptor as downstream markers)ACO1 expression/mutation status for research purposes

Beyond the preview

Go deeper on Aconitase 1 (ACO1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aconitase 1 (ACO1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call